![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | TLL2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1559756 | 6480464 | [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TLL2 mRNA | CTD | PMID:27840820 | TLL2 | Human | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TLL2 mRNA | CTD | PMID:18936297 | TLL2 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TLL2 mRNA | CTD | PMID:23019147 | TLL2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TLL2 mRNA | CTD | PMID:21296121 | TLL2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1559756 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TLL2 mRNA | CTD | PMID:32109520|PMID:33387578 | TLL2 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | EXP | | 6480464 | 2,2',4,4',5-brominated diphenyl ether results in decreased expression of TLL2 mRNA | CTD | PMID:26705709 | TLL2 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of TLL2 mRNA | CTD | PMID:30616060 | TLL2 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of TLL2 gene | CTD | PMID:27153756 | TLL2 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of TLL2 intron | CTD | PMID:30157460 | TLL2 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of TLL2 mRNA | CTD | PMID:23724009|PMID:33167477 | TLL2 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of TLL2 mRNA | CTD | PMID:26705709 | TLL2 | Human | benzo[a]pyrene | decreases expression | ISO | RGD:1312463 | 6480464 | Benzo(a)pyrene results in decreased expression of TLL2 mRNA | CTD | PMID:22228805 | TLL2 | Human | benzo[a]pyrene | decreases methylation | ISO | RGD:1312463 | 6480464 | Benzo(a)pyrene results in decreased methylation of TLL2 intron | CTD | PMID:27901495 | TLL2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of TLL2 exon | CTD | PMID:30157460 | TLL2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of TLL2 promoter | CTD | PMID:27901495 | TLL2 | Human | bisphenol A | decreases expression | ISO | RGD:1559756 | 6480464 | bisphenol A results in decreased expression of TLL2 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | TLL2 | Human | bisphenol A | increases methylation | ISO | RGD:1559756 | 6480464 | bisphenol A results in increased methylation of TLL2 gene | CTD | PMID:28505145 | TLL2 | Human | cadmium dichloride | increases expression | ISO | RGD:1559756 | 6480464 | Cadmium Chloride results in increased expression of TLL2 mRNA | CTD | PMID:33453195 | TLL2 | Human | copper atom | increases expression | ISO | RGD:1559756 | 6480464 | Copper deficiency results in increased expression of TLL2 mRNA | CTD | PMID:26033743 | TLL2 | Human | copper atom | multiple interactions | ISO | RGD:1559756 | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of TLL2 mRNA | CTD | PMID:26033743 | TLL2 | Human | copper(0) | increases expression | ISO | RGD:1559756 | 6480464 | Copper deficiency results in increased expression of TLL2 mRNA | CTD | PMID:26033743 | TLL2 | Human | copper(0) | multiple interactions | ISO | RGD:1559756 | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of TLL2 mRNA | CTD | PMID:26033743 | TLL2 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of TLL2 mRNA | CTD | PMID:26705709 | TLL2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | TLL2 | Human | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of TLL2 mRNA | CTD | PMID:26615145 | TLL2 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of TLL2 mRNA | CTD | PMID:26272509 | TLL2 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | TLL2 | Human | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of TLL2 mRNA | CTD | PMID:23019147 | TLL2 | Human | gentamycin | increases expression | ISO | RGD:1559756 | 6480464 | Gentamicins results in increased expression of TLL2 mRNA | CTD | PMID:33387578 | TLL2 | Human | glyphosate | affects methylation | ISO | RGD:1559756 | 6480464 | Glyphosate affects the methylation of TLL2 gene | CTD | PMID:35440735 | TLL2 | Human | glyphosate | decreases methylation | ISO | RGD:1559756 | 6480464 | Glyphosate results in decreased methylation of TLL2 gene | CTD | PMID:31011160 | TLL2 | Human | methotrexate | affects expression | ISO | RGD:1312463 | 6480464 | Methotrexate affects the expression of TLL2 mRNA | CTD | PMID:18502557 | TLL2 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of TLL2 mRNA | CTD | PMID:28001369 | TLL2 | Human | mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1312463 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of TLL2 mRNA | CTD | PMID:22401849 | TLL2 | Human | okadaic acid | increases expression | EXP | | 6480464 | Okadaic Acid results in increased expression of TLL2 mRNA | CTD | PMID:38832940 | TLL2 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of TLL2 mRNA | CTD | PMID:26690555 | TLL2 | Human | paracetamol | increases expression | ISO | RGD:1559756 | 6480464 | Acetaminophen results in increased expression of TLL2 mRNA | CTD | PMID:33387578 | TLL2 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of TLL2 mRNA | CTD | PMID:26272509 | TLL2 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | TLL2 | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of TLL2 mRNA | CTD | PMID:18070364 | TLL2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | TLL2 | Human | sodium arsenite | decreases expression | ISO | RGD:1312463 | 6480464 | sodium arsenite results in decreased expression of TLL2 mRNA | CTD | PMID:36209798 | TLL2 | Human | Theaflavin 3,3'-digallate | affects expression | EXP | | 6480464 | theaflavin-3,3'-digallate affects the expression of TLL2 mRNA | CTD | PMID:34925699 | TLL2 | Human | titanium dioxide | decreases methylation | ISO | RGD:1312463 | 6480464 | titanium dioxide results in decreased methylation of TLL2 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | TLL2 | Human | trichloroethene | increases expression | ISO | RGD:1559756 | 6480464 | Trichloroethylene results in increased expression of TLL2 mRNA | CTD | PMID:33387578 | TLL2 | Human | triptonide | increases expression | ISO | RGD:1312463 | 6480464 | triptonide results in increased expression of TLL2 mRNA | CTD | PMID:33045310 | TLL2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of TLL2 mRNA | CTD | PMID:28818685 | TLL2 | Human | valproic acid | decreases expression | ISO | RGD:1559756 | 6480464 | Valproic Acid results in decreased expression of TLL2 mRNA | CTD | PMID:29427782 | TLL2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of TLL2 mRNA | CTD | PMID:23179753|PMID:24935251|PMID:28001369 | TLL2 | Human | vinclozolin | decreases methylation | ISO | RGD:1559756 | 6480464 | vinclozolin results in decreased methylation of TLL2 gene | CTD | PMID:31682807 | TLL2 | Human | zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of TLL2 mRNA | CTD | PMID:16330358 | |